Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen D Shafran

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
The Canadian Journal of Infectious Diseases = Journal Canadien Des Maladies Infectieuses|December 27, 2007
Nelfinavir and non-nucleoside reverse transcriptase inhibitor-based salvage regimens in heavily HIV pretreated patientsJean-Guy Baril, Eric A Lefebvre, Richard G Lalonde, et al.
Annals of Hepatology|November 20, 2020
Identifying gaps in the treatment of hepatitis C in patients co-infected with HIV in Edmonton, AlbertaJessica M Round, Bohdan Savaryn, Sabrina S Plitt, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|December 2, 2011
Canadian consensus guidelines for the optimal use of maraviroc in the treatment of HIV-infected adultsAnita Rachlis, Marianne Harris, Richard Lalonde, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|September 3, 2010
Optimal use of raltegravir (Isentress(R)) in the treatment of HIV-infected adults - Canadian consensus guidelinesAnita Rachlis, Jonathan B Angel, Marianne Harris, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 17, 2004
Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trialStephen D Shafran, Stephen K Tyring, Richard Ashton, et al.
Journal of Cutaneous Medicine and Surgery|June 3, 2005
Oral famciclovir for the suppression of recurrent genital herpes: the combined data from two randomized controlled trialsStephen K Tyring, Francisco Diaz-Mitoma, Stephen D Shafran, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|February 1, 2013
Challenges in initiating antiretroviral therapy in 2010Cécile L Tremblay, Jean-Guy Baril, David Fletcher, et al.
The New England Journal of Medicine|July 13, 2007
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3Mitchell L Shiffman, Fredy Suter, Bruce R Bacon, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|December 2, 2011
Canadian clinical practice guidelines for invasive candidiasis in adultsEric J Bow, Gerald Evans, Jeff Fuller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 2, 2002
Field evaluation of the Merlin immediate HIV-1 and -2 test for point-of-care detection of human immunodeficiency virus antibodiesStephen D Shafran, Brian Conway, Errol Prasad, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
The Canadian Journal of Infectious Diseases = Journal Canadien Des Maladies Infectieuses|December 27, 2007
Nelfinavir and non-nucleoside reverse transcriptase inhibitor-based salvage regimens in heavily HIV pretreated patientsJean-Guy Baril, Eric A Lefebvre, Richard G Lalonde, et al.
Annals of Hepatology|November 20, 2020
Identifying gaps in the treatment of hepatitis C in patients co-infected with HIV in Edmonton, AlbertaJessica M Round, Bohdan Savaryn, Sabrina S Plitt, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|December 2, 2011
Canadian consensus guidelines for the optimal use of maraviroc in the treatment of HIV-infected adultsAnita Rachlis, Marianne Harris, Richard Lalonde, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|September 3, 2010
Optimal use of raltegravir (Isentress(R)) in the treatment of HIV-infected adults - Canadian consensus guidelinesAnita Rachlis, Jonathan B Angel, Marianne Harris, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 17, 2004
Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trialStephen D Shafran, Stephen K Tyring, Richard Ashton, et al.
Journal of Cutaneous Medicine and Surgery|June 3, 2005
Oral famciclovir for the suppression of recurrent genital herpes: the combined data from two randomized controlled trialsStephen K Tyring, Francisco Diaz-Mitoma, Stephen D Shafran, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|February 1, 2013
Challenges in initiating antiretroviral therapy in 2010Cécile L Tremblay, Jean-Guy Baril, David Fletcher, et al.
The New England Journal of Medicine|July 13, 2007
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3Mitchell L Shiffman, Fredy Suter, Bruce R Bacon, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|December 2, 2011
Canadian clinical practice guidelines for invasive candidiasis in adultsEric J Bow, Gerald Evans, Jeff Fuller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 2, 2002
Field evaluation of the Merlin immediate HIV-1 and -2 test for point-of-care detection of human immunodeficiency virus antibodiesStephen D Shafran, Brian Conway, Errol Prasad, et al.
Pageof 4